Janssen

Select Product *

Keywords *

Drug *

Leave this field blank

JANSSEN MEDICAL INFORMATION

Monday-Friday (8:30AM - 4:30PM ET)

Toll Free 1-800-567-3331

Reminder to Please Call us...

To report a possible adverse event or product quality complaint
If you have an urgent question on one of the products from Janssen

JANSSEN MEDICAL INFORMATION

Monday-Friday (8:30 AM - 4:30PM EST)

Toll Free: 1-800-567-3331

Continue

Janssen COVID-19 Vaccine

You are about to review information on the Janssen COVID-19 Vaccine. Please select the following that would apply to you:

I am a Healthcare Professional in Canada I am a consumer or caregiver in Canada I am a US Healthcare Professional I am a US consumer or caregiver

Home
COVID-19 Vaccine
Product Monographs
Submit a Question
Compassionate Use

English
Français

JCOVDEN

JCOVDEN™ (COVID-19 Vaccine (Ad26.COV2-S [recombinant])) is indicated for active immunization for the prevention of coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 virus in individuals 18 years of age and older. JCOVDEN must be injected intramuscularly only. Drug Identification Number (DIN): 02513153.
General Information on COVID-19 Vaccines
Johnson & Johnson Press Releases
Cannot find what you are looking for?

JCOVDEN Patient Medical Information
Report a side effect

Janssen Contact Centre

If you have questions about JCOVDEN™, our call centre healthcare providers are available at:

1-800-567-3331 (Toll Free)

Monday-Friday (8:30 AM – 4:30 PM EST)

Public Health Agency Of Canada

To monitor vaccine safety, the Public Health Agency of Canada collects information on serious and unexpected reports of adverse events following immunization. Should you experience an adverse event following immunization, please ask your doctor, nurse, or pharmacist to complete the Adverse Events Following Immunization (AEFI) Form or call:

1-866-844-0018 (Toll Free)

Janssen Contact Centre

If you wish to report a side effect to Janssen, please call:

1-800-567-3331 (Toll Free)

Monday-Friday (8:30 AM – 4:30 PM EST)

This site is intended for Healthcare Professionals from Canada only and is published by Janssen Inc., which is solely responsible for its contents. Your use of this information on this site is subject to our Legal Notice. Please see our Privacy Policy. VELCADE^® is a trademark of Millennium Pharmaceuticals, Inc.

This site was last modified on: December 5, 2022

Terms and Conditions for Using this Website

By selecting I Accept:

I have read and agree to the Legal Notice and Privacy Policy of this Web site.*

You are a healthcare professional in Canada and that you will only use the information provided on this website as an informational aid for your use only and that you will not disseminate to gain profit from this information.

The information provided to you by Janssen Inc. is not medical advice/recommendations and that the information provided to you is in response to your specific unsolicited request for information.

Janssen Inc. only recommends the use of these products in a manner as described in the Health Canada approved product monograph.

You agree that Janssen Inc., and companies working with Janssen Inc., may passively collect personally identifiable browsing information to customize the site based on your preferences, compile and analyze statistics and trends, and otherwise administer and improve the site for your use.

I do not accept

External Link Page

This link will take you to another website that is unrelated to the Janssen Inc. Medical Information website and to which the Legal Notice and Privacy Policy of the Janssen Inc. Medical Information website do not apply. We encourage you to read the Legal Notice and Privacy Policy of every website you visit. Click the Return button to return to www.janssenmedicalinformation.ca or Continue to continue.

Continue